GENE ONLINE|News &
Opinion
Blog

Alzheimer's Disease
Trials & Approvals Alzheimer's Disease
Roche Bags Fast Track Label for New Alzheimer’s Diagnostic
2022-07-21
Technology Dementia
Alleviating Depression and Dementia with Transcorneal Electrical Stimulation
2022-07-11
R&D Alzheimer's Disease
Are Memory Loss in Alzheimer’s Disease Related to Changes in Blood Vessels in the Brain?
2022-07-07
Funding Neurodegenerative Disease
NRG Therapeutics Wins £2.68M to Treat Chronic Neurodegenerative Disorders
2022-05-31
Regulatory Alzheimer's Drug
Eisai to File Another Biogen-Partnered Alzheimer’s Drug After Confidence Hit
2022-05-10
Trials & Approvals Alzheimer's Disease
FDA Greenlights First In-Vitro Alzheimer’s Diagnostic
2022-05-05
Trials & Approvals Biogen
Biogen Halts Aduhelm’s Second EU Marketing Application
2022-04-25
Biotech Brain Atrophy
The Brain Size Changes with Age: A First Worldwide Brain Study
2022-04-20
Regulatory Alzheimer's Drug
CMS’s New Ruling on Biogen’s Aduhelm Restriction Coverage
2022-04-13
Biotech Alzheimer's Disease
MGC Pharmaceuticals Enters Partnership with Sciensus Rare for Distribution of Cannabinoids to Treat Refractory Epilepsy, Dementia and Alzheimer’s in the EU and UK
2022-04-05
Deals South Korea
Alliance Formed: SV Investment and Orange Grove Bio Jointly Source and Develop Novel Medications in the U.S. and Korea
2022-03-16
Special 2022 psychedelics
From Forbidden Drugs to Psychotropic Cures: A “Psychedelic Boom” Breaks New Ground in Treating Mental Illnesses
2022-03-08
M&A Neuroscience
Abbvie Acquires Neuroscience Company Syndesi for $1 Billion
2022-03-02
Asia-Pacific Neurodegenerative Disease
Japan’s Ono Pharmaceutical Expands Collab with Neurimmune to Discover Antibodies for Neurodegenerative Disorders
2022-01-18
Ranking & Reports
GeneOnline’s Top 10 Editor’s Picks for 2021
2021-12-23
1 2 3 4 5 6
LATEST
Exosomes: What They Do and Who’s Doing What
2025-04-21
Eli Lilly’s Orforglipron Shows Phase 3 Success: First Oral GLP-1 Drug for Type 2 Diabetes and Weight Loss
2025-04-21
Dupixent Makes History with FDA Approval as First New CSU Treatment in Over a Decade
2025-04-20
Multiple PCV Doses May Be Needed for Immunocompromised Type 2 Diabetics to Maintain Protection, Study Finds
2025-04-19
Multiple PCV Doses May Be Needed for Immunocompromised Individuals with Type 2 Diabetes
2025-04-19
Dr. Lauren Krupp, FAAN, Advocates Early Intervention and Family Support in Pediatric MS Treatment.
2025-04-19
Dr. Lauren B. Krupp Recommends Early, Aggressive Treatment with High-Efficacy Therapies for Pediatric Multiple Sclerosis
2025-04-19
READ MORE
EVENT
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-04-26
SABPA OC/LA 17th Annual Biomedical Forum
Irvine, California, United States
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
2025-05-05
Swiss Biotech Day 2025
Basel, Switzerland
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top